VILEA NEUROLOGY: what changed
VILEA NEUROLOGY
Largest movements
- Cash +€99,655
up €99,655 (+412%), from €24,197 to €123,851
mainly Net result for the year (+€81,843) and Current investments (+€38,621)
- Current investments -€38,621
down €38,621 (-22.2%), from €174,307 to €135,686
- Profit (loss) carried forward +€81,843
up €81,843 (+43.5%), from €188,336 to €270,179
- Tax, wage and social debts -€21,280
down €21,280 (-88.3%), from €24,113 to €2,832
- Gross operating margin -€12,357
down €12,357 (-10.5%), from €117,133 to €104,776
- Taxes -€3,160
down €3,160 (-13.1%), from €24,113 to €20,952
- Depreciation +€1,442
up €1,442 (+315%), from €457 to €1,899
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €217,845 | €277,194 | +€59,349 | +27.2% |
| Fixed assets | 21/28 | €5,420 | €4,982 | -€438 | -8.1% |
| Tangible fixed assets | 22/27 | €5,420 | €4,982 | -€438 | -8.1% |
| Furniture and vehicles | 24 | €5,420 | €4,982 | -€438 | -8.1% |
| Current assets | 29/58 | €212,424 | €272,211 | +€59,787 | +28.1% |
| Amounts receivable within one year | 40/41 | €10,154 | €10,846 | +€692 | +6.8% |
| Trade receivables | 40 | €10,154 | €10,846 | +€692 | +6.8% |
| Current investments | 50/53 | €174,307 | €135,686 | -€38,621 | -22.2% |
| Cash at bank and in hand | 54/58 | €24,197 | €123,851 | +€99,655 | +412% |
| Deferred charges and accrued income | 490/1 | €3,766 | €1,828 | -€1,938 | -51.5% |
| Total equity and liabilities | 10/49 | €217,845 | €277,194 | +€59,349 | +27.2% |
| Equity | 10/15 | €190,336 | €272,179 | +€81,843 | +43.0% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €188,336 | €270,179 | +€81,843 | +43.5% |
| Amounts payable | 17/49 | €27,509 | €5,015 | -€22,494 | -81.8% |
| Amounts payable within one year | 42/48 | €27,509 | €5,015 | -€22,494 | -81.8% |
| Trade debts | 44 | €1,363 | €1,642 | +€279 | +20.5% |
| Suppliers | 440/4 | €1,363 | €1,642 | +€279 | +20.5% |
| Taxes, remuneration and social security | 45 | €24,113 | €2,832 | -€21,280 | -88.3% |
| Taxes | 450/3 | €24,113 | €2,832 | -€21,280 | -88.3% |
| Other amounts payable | 47/48 | €2,034 | €541 | -€1,493 | -73.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €457 | €1,899 | +€1,442 | +315% |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €117,133 | €104,776 | -€12,357 | -10.5% |
| Operating profit (loss) | 9901 | €116,291 | €102,489 | -€13,802 | -11.9% |
| Financial income | 75/76B | €940 | €1,117 | +€177 | +18.8% |
| Recurring financial income | 75 | €940 | €1,117 | +€177 | +18.8% |
| Financial charges | 65/66B | €801 | €810 | +€10 | +1.2% |
| Recurring financial charges | 65 | €801 | €810 | +€10 | +1.2% |
| Profit (loss) for the period before taxes | 9903 | €116,430 | €102,795 | -€13,635 | -11.7% |
| Income taxes | 67/77 | €24,113 | €20,952 | -€3,160 | -13.1% |
| Profit (loss) for the period | 9904 | €92,317 | €81,843 | -€10,475 | -11.3% |
| Profit (loss) for the period to be appropriated | 9905 | €92,317 | €81,843 | -€10,475 | -11.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.